Filing Flows › 10x Genomics (TXG) › Free cash flow
10x Genomics (TXG) free cash flow by quarter
10x Genomics' free cash flow was $14.9M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $14.9M (Q3 2026) to $42.5M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $14.9M | -3% | -65% |
| Q2 2026 | $15.4M | -37% | -5% |
| Q1 2026 | $24.5M | -37% | -24% |
| Q4 2025 | $39.0M | -8% | — |
| Q3 2025 | $42.5M | +164% | — |
| Q2 2025 | $16.1M | -50% | — |
| Q1 2025 | $32.5M | — | — |
Q3 2026 at a glance
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is 10x Genomics' free cash flow?
10x Genomics' free cash flow was $14.9M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has 10x Genomics' free cash flow changed?
Over the last 7 quarters it ranged from $14.9M (Q3 2026) to $42.5M (Q3 2025).